CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Shares withheld for taxes SVP & Chief Compliance Officer gave up 2,133 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & General Counsel gave up 6,327 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes President and CEO gave up 41,717 shares (to pay taxes)
- 4 Open-market sale Director sold 10,000 shares at $7.57 ($75,658)
- 144 Insider Sale of Securities
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 17,701 shares at $7.42 ($131,255)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 4 Option exercise Director acquired 7,575 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
Page 3 of 24 · 463 filings